Marea Therapeutics
Clinical trials sponsored by Marea Therapeutics, explained in plain language.
-
New drug MAR002 takes first step toward treating acromegaly
Disease control Recruiting nowThis Phase 1 trial tests the safety of a new drug called MAR002 in 45 healthy men. Participants receive either MAR002 or a placebo by injection. The goal is to see if it's safe and how the body processes it, before testing it in people with acromegaly.
Phase: PHASE1 • Sponsor: Marea Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New shot aims to tame After-Meal fat spikes in High-Risk patients
Disease control Recruiting nowThis Phase 2 study tests whether the drug MAR001 can lower blood fat levels after a meal in adults with high triglycerides. Thirty participants will receive either MAR001 or a placebo injection. The main goal is to see if MAR001 reduces the rise in triglycerides and remnant chole…
Phase: PHASE2 • Sponsor: Marea Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC